Search
for
Sort by
Research 181–210 of 1000+
- Cancer Treatments and Alopecia: A Systematic Review
- Sorafenib-induced Facial Acneiform Eruption
- Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
- Wound Healing: A Cellular Perspective
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- RNA sequence analysis of dermal papilla cells’ regeneration in 3D culture
- Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
- Abstracts
- Sesamin alleviates androgenetic alopecia by targeting the AR MAPK Wnt axis
- An autosomal recessive nonsense variant in the EGFR gene induces perinatal lethality in “Blonde d'Aquitaine” calves
- Clinical-Exome Sequencing Unveils the Genetic Landscape of Polycystic Ovarian Syndrome (PCOS) Focusing on Lean and Obese Phenotypes: Implications for Cost-Effective Diagnosis and Personalized Treatment
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Data from Synergistic Function of Smad4 and PTEN in Suppressing Forestomach Squamous Cell Carcinoma in the Mouse
- Data from Synergistic Function of Smad4 and PTEN in Suppressing Forestomach Squamous Cell Carcinoma in the Mouse
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Differential activity of 2-methylene-19-nor vitamin D analogs on growth factor gene expression in rhino mouse skin and comparison to all-trans retinoic acid
- Epidermal growth factor receptor inhibitors and hair
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Cutaneous drug reactions
- Mechanism of action of herbs and their active constituents used in hair loss treatment
- The PDGF/PDGFR pathway as a drug target
- Ritlecitinib: First Approval
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea